GUGLIELMO, ALBA
 Distribuzione geografica
Continente #
AS - Asia 2.090
NA - Nord America 1.775
EU - Europa 1.100
Continente sconosciuto - Info sul continente non disponibili 132
SA - Sud America 103
AF - Africa 100
OC - Oceania 2
Totale 5.302
Nazione #
US - Stati Uniti d'America 1.731
VN - Vietnam 557
SG - Singapore 555
CN - Cina 487
IT - Italia 360
SE - Svezia 158
HK - Hong Kong 138
DE - Germania 137
GB - Regno Unito 94
IN - India 82
KR - Corea 74
BR - Brasile 70
NL - Olanda 57
BD - Bangladesh 55
RU - Federazione Russa 50
FR - Francia 48
IE - Irlanda 41
AT - Austria 33
CI - Costa d'Avorio 33
JP - Giappone 29
ZA - Sudafrica 29
FI - Finlandia 25
CA - Canada 23
AR - Argentina 20
ID - Indonesia 16
TG - Togo 16
BG - Bulgaria 15
PH - Filippine 15
CH - Svizzera 14
JO - Giordania 13
ES - Italia 11
MX - Messico 11
PL - Polonia 11
TR - Turchia 11
IQ - Iraq 10
TH - Thailandia 9
UA - Ucraina 9
HR - Croazia 8
EC - Ecuador 7
PK - Pakistan 7
SC - Seychelles 7
TW - Taiwan 7
LT - Lituania 6
NG - Nigeria 5
AE - Emirati Arabi Uniti 4
GR - Grecia 4
UZ - Uzbekistan 4
DK - Danimarca 3
IR - Iran 3
JM - Giamaica 3
PT - Portogallo 3
PY - Paraguay 3
SA - Arabia Saudita 3
AU - Australia 2
AZ - Azerbaigian 2
EG - Egitto 2
ET - Etiopia 2
IL - Israele 2
MA - Marocco 2
RO - Romania 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GD - Grenada 1
HN - Honduras 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PE - Perù 1
RE - Reunion 1
SK - Slovacchia (Repubblica Slovacca) 1
SV - El Salvador 1
Totale 5.170
Città #
Singapore 394
Ashburn 189
Chandler 173
Hefei 164
San Jose 162
Ho Chi Minh City 137
Hong Kong 130
Hanoi 112
Santa Clara 98
Bologna 79
Dong Ket 74
Southend 69
Seoul 66
Beijing 57
Council Bluffs 56
Fairfield 55
Los Angeles 45
Boardman 44
Dublin 41
Princeton 40
New York 39
Houston 34
Abidjan 33
Dallas 33
Milan 31
Vienna 30
Lauterbourg 28
Tokyo 26
Redmond 24
Wilmington 24
Johannesburg 22
Haiphong 20
Seattle 19
Rome 18
Munich 17
Da Nang 16
Lomé 16
Turin 16
Woodbridge 16
Cambridge 15
Helsinki 15
Sofia 15
Bengaluru 14
Frankfurt am Main 14
Amman 13
Berlin 13
Buffalo 13
Des Moines 12
Redondo Beach 12
Ann Arbor 11
Bremen 11
Phoenix 11
Verona 11
Bern 9
Florence 9
Jakarta 9
San Diego 9
São Paulo 9
Quận Bình Thạnh 8
Warsaw 8
Atlanta 7
Delhi 7
Kuban 7
London 7
Nuremberg 7
Piacenza 7
Toronto 7
Amsterdam 6
Biên Hòa 6
Guangzhou 6
San Francisco 6
Turku 6
Abeokuta 5
Bắc Giang 5
Bắc Ninh 5
Chicago 5
Denver 5
Genoa 5
Hyderabad 5
Hải Dương 5
Manchester 5
Nanjing 5
Naples 5
Pune 5
Redwood City 5
Taranto 5
Thái Nguyên 5
Yubileyny 5
Bangkok 4
Bari 4
Can Tho 4
Catania 4
Chongqing 4
Hangzhou 4
Jinan 4
Lappeenranta 4
Mexico City 4
Montreal 4
Philadelphia 4
The Dalles 4
Totale 3.095
Nome #
Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective 243
Acral skin eruption observed during SARS-CoV-2 pandemic: possible keratolysis exfoliativa with red palms and soles 222
Herpes zoster in COVID-19-positive patients 211
Disseminate Recurrent Folliculitis and Hidradenitis Suppurativa Are Associated Conditions: Results From a Retrospective Study of 131 Patients With Down Syndrome and a Cohort of 12,351 Pediatric Controls 197
PTEN Hamartoma Tumor Syndrome: Skin Manifestations and Insights Into Their Molecular Pathogenesis 195
Cutaneous squamous cell carcinoma progression during imiquimod treatment 179
Primary Cutaneous CD4+ Small/Medium T-Cell Lymphoproliferative Disorders (SMPLPD), demographical, clinical, therapeutic and prognostic aspects: a retrospective monocentric analysis 170
Cutaneous adverse-events in patients treated with Ibrutinib 170
Chilblain lesions after COVID-19 mRNA vaccine 166
Clinical and trichoscopic features in 18 cases of Folliculotropic Mycosis Fungoides with scalp involvement 165
Terra firma-forme dermatosis: a systematic review 164
New insights into alopecia areata during COVID-19 pandemic: When infection or vaccination could play a role 160
Biological therapy in patients with psoriasis: What we know about the effects on renal function 158
Primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder nodule successfully treated with laser Co2 ablation: a case report and literature review 158
A Narrative Review of the State of the Art of CCR4-Based Therapies in Cutaneous T-Cell Lymphomas: Focus on Mogamulizumab and Future Treatments 158
Estimating the incidence of COVID-19 skin manifestations on the general population in a territorial setting 158
Bexarotene as maintenance treatment after therapies other than skin-directed therapy in advanced-stage mycosis fungoides: a pilot study 154
A Case of Bullous Rash Apparently Triggered by Meningococcal and Rotavirus Vaccines in an Infant: Focus on Infantile Bullous Pemphigoid 139
Erythroderma with brentuximab vedotin (skin side effects in mycosis fungoides) 138
Erythrodermie mit Brentuximab‐Vedotin (Hautnebenwirkungen bei Mycosis fungoides) 136
Major cluster of paediatric ‘true’ primary chilblains during the COVID-19 pandemic: a consequence of lifestyle changes due to lockdown 126
Dermoscopy of chilblain-like lesions during the COVID-19 outbreak: A multicenter study on 10 patients 126
Generalized granuloma annulare-like eruption secondary to acute Epstein–Barr virus infection 121
Violaceous Papules and Plaques on the Fingers during COVID-19: A Quiz 114
Chilblains in a child with confirmed SARS-CoV-2 infection: a red flag for late-onset skin manifestation in previously infected individuals 107
PD-1 and PD-L1 expression in mycosis fungoides and Sézary Syndrome 104
Immune-Mediated Dermatoses in Patients with Haematological Malignancies: A Comprehensive Review 103
The microenvironment’s role in mycosis fungoides and sézary syndrome: From progression to therapeutic implications 100
Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives 100
'Colouring' wipes phenomenon: a peculiar skin pigmentation induced by ascorbic acid observed during lockdown 87
The red half-moon nail sign: a novel manifestation of coronavirus infection. 79
OX40–OX40L Axis in Cutaneous T-Cell Lymphomas: Pathogenic, Prognostic, and Potential Therapeutic Perspectives 78
New insights into the oncological risk in heart transplant recipients: could skin tumors represent a marker of increased risk for solid neoplasm? 73
Effectiveness and safety of baricitinib in severe alopecia areata: 48-week results 72
Vulvar vitiligo and lichen sclerosus in children: A clinical challenge 67
Non-Melanoma Skin Cancer in Transplant Recipients: A Single-Centre Retrospective Cohort Study on the Role of Transplant Type, Immunosuppressive Exposure, and Tumor Subtypes 63
Second neoplasm in cutaneous T-cell lymphoma patients: a marker of worse prognosis? 58
Chlormethine gel effectiveness as second-line treatment in mycosis fungoides: a single-centre retrospective study 57
Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome 52
Interleukin‐13 inhibition and cancer risk: reply to Tang and Chen 48
Mogamulizumab-induced alopecia. Multicentric case series: Clinical, trichoscopic and histological characterization. 47
Skin toxicities related to Bruton tyrosine kinase inhibitors: an updated review 44
Oral pigmentation in children: a diagnostic challenge 35
Totale 5.302
Categoria #
all - tutte 16.270
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.270


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022428 0 9 20 57 32 20 7 44 28 38 109 64
2022/2023590 48 78 44 77 54 61 23 48 79 17 37 24
2023/2024215 14 40 16 27 18 49 7 16 2 6 1 19
2024/2025944 34 114 79 89 118 35 80 44 7 69 76 199
2025/20262.503 213 301 195 160 229 122 169 120 510 227 154 103
2026/2027275 162 113 0 0 0 0 0 0 0 0 0 0
Totale 5.302